Beth Bioinformatics Co., Ltd

Beth Bioinformatics (BethBio) is a biotech company that develops state-of-the-art technologies to empower the development of new and better vaccines. Utilizing virology, AI and computational biology, BethBio provides a series of innovating bioinformatics solutions to pharmaceutical companies, including virus evolution prediction for SARS-CoV-2 and Influenza, real-time vaccine effectiveness (VE) evaluation, codon (de)optimization , epitope screening, antigen design and more. These solutions could help our clients solve various technical difficulties such as protein expression, improve efficacy or manufacture efficiency of their products, and identify potent epitopes for candidates such as broadly-reactive T-cell or cancer vaccines. In addition, the company also develops accurate and robust human genome interpretation technologies for improved human disease prediction, that could be applied to multi-population data and achieve true-individualized prediction. The company is working closely with pharmaceutical and genetic-testing companies, including several new vaccine co-development projects.